Concord Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
CONCORDBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Concord Biotech has informed the stock exchanges that its trading window will be closed from 1st July 2025 until 48 hours after the company declares its unaudited financial results for the quarter ended 30th June 2025 (Q1 FY26). This is a standard compliance requirement under SEBI's Insider Trading Regulations. During this period, all designated persons of the company and their immediate relatives are prohibited from trading in the company's shares. The company will separately announce the date of the board meeting where the Q1 results will be approved.
This is a routine regulatory announcement with no direct impact on shareholders or stock price. It signals that the Q1 FY26 results announcement is approaching, which investors should watch for.